Advertisement

Topics

Vertex Pharmaceuticals Inc. Company Profile

01:38 EDT 22nd June 2018 | BioPortfolio

Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative new medicines so people with serious diseases can lead better lives. Founded in 1989, Vertex today employs more than 2,000 people at sites around the world.  In addition to our headquarters in Massachusetts, Vertex has research and development sites and other offices in San Diego, CA; Abingdon, Oxfordshire, UK; Laval, Quebec; Coralville, IA; and Geneva, Switzerland.

In May 2011, the U.S. Food and Drug Administration (FDA) approved Vertex’s first medicine, a treatment for hepatitis C.  In January 2012, Vertex received FDA approval for our medicine for cystic fibrosis. Vertex received European approval of our medicine for cystic fibrosis in July 2012.

In addition to our approved medicines, we are developing new combinations of medicines that could further advance treatment of hepatitis C and cystic fibrosis.  We also have a broad pipeline of other potential new medicines currently in early and mid-stage development for diseases such as rheumatoid arthritis, influenza and other diseases.

We collaborate with some of the world’s largest pharmaceutical companies, leading nonprofit disease foundations and many of the world’s best-known academic institutions.

Location

130 Waverly Street
Cambridge
MA
02139-4242
United States of America

Contact

Phone: 617-341-6100
Fax: 617-444-6680


News Articles [684 Associated News Articles listed on BioPortfolio]

Vertex Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates

CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Inc. (VRTX) released a profit for first quarter that fell from last year.The company's bottom line came in at $210 million, or $0.81 pe...

Analysts Expect Vertex Pharmaceuticals Incorporated (VRTX) Will Announce Earnings of $0.57 Per Share

Wall Street brokerages expect Vertex Pharmaceuticals Incorporated to report earnings of $0.57 per share for the current quarter, according to Zacks Investment Research . Ten analysts have made estimat...

Vertex Pharmaceuticals erzielt einen wichtigen Fortschritt

Die rasch ansteigenden Umsätze der beiden Mukoviszidose-Medikamente von Vertex Pharmaceuticals (WKN:882807) führten dazu, dass das Unternehmen im vergangenen Jahr zu den Top-Aktien zählte. Das Mana...

Vertex Pharmaceuticals Inc. Reveals Advance In Q4 Profit

CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Inc. (VRTX) reported a profit for its fourth quarter that gained ground compared to the same period last year.The company said its bott...

Vertex Pharma Gets FDA Approval for Combo CF Drug, Sets $292,000 Price

The FDA has approved a new Vertex Pharmaceuticals cystic fibrosis drug, clearing the way for the Boston company to bring to the market its third treatment for the inherited disorder. The new Vertex (N...

Vertex Pharmaceuticals-Aktie: Kaum bekannt - aber äußerst spannend!

Vertex Pharmaceuticals ist ein Pharmaunternehmen aus den USA. Hier sind die Produkte und das Unternehmen wohl nicht so bekannt, wie auch ein Blick auf das oft geringe Handelsvolumen an den Märkten .....

Interview Insider: Tips on How to Get Hired at Vertex Pharmaceuticals

Here is some insight on what Vertex may be looking for in their employees.

Interview Insider: Tips on How to Get Hired by Vertex Pharmaceuticals

Here is some insight on what Vertex may be looking for in their employees.

Drugs and Medications [295 Associated Drugs and Medications listed on BioPortfolio]

Minoxidil [Hi-Tech Pharmacal Co., Inc.]

Drug Facts

Hair regrowth treatment [Safeway]

Safeway Inc. Hair Regrowth Treatment for Men Drug Facts

Hair regrowth [CVS Pharmacy]

CVS Pharmacy, Inc. Hair Regrowth Treatment for Men Drug Facts

Equaline hair regrowth treatment [Supervalu Inc]

SuperValu Hair Regrowth Treatment for Men Drug Facts

Hair regrowth treatment [Meijer Distribution Inc]

Meijer Hair Regrowth Treatment for Men Drug Facts

PubMed Articles [214 Associated PubMed Articles listed on BioPortfolio]

Spontaneous Version of Fetal Presentation in Twin Pregnancies During Third Trimester: Longitudinal Assessment.

Little is known about longitudinal changes of the first twin presentation in twin gestations. This is a retrospective cohort study including 411 women who were admitted consecutively and delivered liv...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Variation in the Nulliparous, Term, Singleton, Vertex Cesarean Delivery Rate.

To estimate the contributions of patient and health care provider-hospital characteristics to the variation in the frequency of nulliparous, term, singleton, vertex cesarean delivery in a multi-instit...

Structure of the herpes simplex virus portal-vertex.

Herpesviruses include many important human pathogens such as herpes simplex virus, cytomegalovirus, varicella-zoster virus, and the oncogenic Epstein-Barr virus and Kaposi sarcoma-associated herpesvir...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Clinical Trials [224 Associated Clinical Trials listed on BioPortfolio]

Early Versus Delayed Pushing in the Second Stage of Labor

Nulliparous women in spontaneous or induced labour with term singleton pregnancy are randomized into two groups first group (early pushing) in this group patients were allowed to push with...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Companies [1323 Associated Companies listed on BioPortfolio]

Vertex Pharmaceuticals Inc.

Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative new medicines so people with serious diseases can lead better lives. Founded in 1989, Vertex toda...

Vertex Pharmaceuticals Incorporated

Second Quarter and Six Month Results

LaVoie Group

LaVoie Group provides senior-level strategic counsel and tactical implementation of strategic communications programs designed to properly position, create visibility and drive value for each client. ...

Palleon Pharmaceuticals

Palleon Pharmaceuticals is the leading biotechnology company focused on developing Glycoimmune Checkpoint inhibitors to treat cancer. The company’s proprietary Convergence Pl...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

More Information about "Vertex Pharmaceuticals Inc." on BioPortfolio

We have published hundreds of Vertex Pharmaceuticals Inc. news stories on BioPortfolio along with dozens of Vertex Pharmaceuticals Inc. Clinical Trials and PubMed Articles about Vertex Pharmaceuticals Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vertex Pharmaceuticals Inc. Companies in our database. You can also find out about relevant Vertex Pharmaceuticals Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...


Corporate Database Quicklinks



Searches Linking to this Company Record